Non-opioid Pain Patch Market Size & Share, by Product Type (Lidocaine Patch, Diclofenac Patch, Methyl Salicylate Patch, Capsaicin Patch, Ketoprofen Patch); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5423
  • Published Date: Nov 30, 2023
  • Report Format: PDF, PPT

Companies Dominating the Non-opioid Pain Patch Market

top-features-companies
    • Sanofi S.A.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • GlaxoSmithKline Plc.
    • Pfizer Inc.
    • Clarion Brands
    • Endo Pharmaceuticals
    • TEH SENG Pharmaceutical
    • Teva Pharmaceutical Industries Ltd.
    • Teikoku Seiyaku Co. Ltd.
    • Veridian Healthcare
    • Sorrento Therapeutics (SCILEX Pharmaceuticals Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • GlaxoSmithKline Plc. Received approval from the U.S. Food and Drug Administration for Voltaren Arthritis Pain a nonsteroidal anti-inflammatory drug for the momentary alleviation of arthritis pain, and to enhance public health by expanding the range of medications to the millions of people who experience everyday joint pain from arthritis.
  • Scilex Holding Company announced to boost the production of ELYXYB to obtain, and create non-opioid painkillers to deliver fast and long-lasting migraine relief, and also allow doctors an additional tool for managing pain.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5423
  • Published Date: Nov 30, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing burden of diabetes across the globe and The growing development of advanced products are the major factors driving the growth of the market.

The market size of non-opioid pain patch is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2024-2036.

The major players in the market are GlaxoSmithKline Plc., Pfizer Inc., Hisamitsu Pharmaceutical Co., Inc., Clarion Brands, Endo Pharmaceuticals, TEH SENG Pharmaceutical, Teva Pharmaceutical Industries Ltd., Teikoku Seiyaku Co. Ltd., Veridian Healthcare, Sorrento Therapeutics (SCILEX Pharmaceuticals Inc., and others.

The lidocaine patch segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying